@RNA_Ken

RNA/cancer postdoctoral researcher with @KristenWLynch1 and @YosephBarash at @PennMedicine @SRC_CRS SNGS scholar MOVED TO MASTODON @RNA_Ken@genomic.social

Joined February 2020
Nouveau labo! Je cherche des étudiant(e)s gradué(e)s voulant travailler dans le domaine de l'épissage de l'ARN en #cancer et #immunologie. New lab! I'm looking for grad students interested in #RNAsplicing in #cancer and #immunology mqvlab.com @jrRNAscientists
5
9
1
13
2,159
Mathieu Quesnel-Vallieres retweeted
Oops I did it again: A single, searchable, sortable, spreadsheet of all presentations at #ISMBECCB2023 docs.google.com/spreadsheets… Have fun planning your conference!
5
45
5
165
20,501
RT @[email protected] Reminder of our upcoming online journal club tomorrow, May 2 at 15:30GMT/11:30EDT/8:30PT. We will be discussing RNA structural switches discovery with 1st author khorms57 Register: pennmedicine.zoom.us/meeting… RNASociety iscb genomic.social/@iRnaCosi/110…
175
RT @[email protected] Our sister journals Dev_journal J_Cell_Sci J_Exp_Biol & DMM_Journal offer Travelling Fellowships of up to £3,000 to #biology #PhD students & #Postdocs wishing to make collaborative visits to other laboratories. Next application deadline is 5 (1/2)
1
142
93
RT @[email protected] #NPR should run their own #Mastodon instance as should every other serious news outfit. This bullshit where supposedly serious news organizations should have to capitulate to the whims of some narcissistic billionaire or corrupt government is (1/2)
1
1
124
exactly why the reputation of #journalism everywhere has been dragged through the mud. You are all simply puppets if you cannot create, support and / or foster a framework that supports journalistic freedom and integrity. mstdn.party/@Suig/1101709955… (2/2)
79
The NIH will be taking comments from the postdoc community over the next few days. Topics of high importance are on the agenda: - Role, duration, structure, and value of the postdoc - International trainee concerns - Compensation and benefits - Job security, career (1/2)
1
4
2
1,709
RT @snolen@journa.host Maybe you've heard about Trikafta, the 'miracle' drug that has transformed life for people with cystic fibrosis in North America and Europe? It costs $322,000 a year, and patients take it for life. Turns out the drug isn't available for CF (1/3)
1
1
172
patients anywhere in the developing world. And they say that's on purpose: that the maker, Vertex Pharmaceuticals, is deliberately obstructing access so as to be able to maintain that price (2/3)
1
103
RT @[email protected] My latest clinical pipeline column for NatureMedicine is out today. It's a look at the recent approval of mosunetuzumab, #Genentech's bispecific anti CD20/CD3 monoclonal antibody for relapsed or refractory follicular (1/2)
1
3
238